Filing Details
BioRestorative Therapies, Inc. (NASDAQ:BRTX) filed a Form 8-K with the Securities and Exchange Commission on July 16, 2026, disclosing a material event.
8k filedNASDAQ:BRTX
BioRestorative Therapies, Inc. (BRTX) Reports Material Event to SEC
Filing Details BioRestorative Therapies, Inc. (NASDAQ:BRTX) filed a Form 8-K with the Securities and Exchange Commission on July 16, 2026, disclosing a material event. Market…
Market Context
BioRestorative Therapies, Inc.'s stock currently trades at $0.35 with a market capitalization of $9.5M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for BioRestorative Therapies, Inc.'s stock.
All SEC filings for BioRestorative Therapies, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View BRTX Stock Page
Frequently Asked Questions
Where can I read BRTX's SEC filings?
Browse all filings on our BRTX SEC filings page.
What types of SEC filings does BioRestorative Therapies, Inc. file?
Public companies like BioRestorative Therapies, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.
